Cerevel Therapeutics
CERE
#1951
Rank
$8.19 B
Marketcap
$44.96
Share price
0.00%
Change (1 day)
108.24%
Change (1 year)

P/E ratio for Cerevel Therapeutics (CERE)

P/E ratio on October 3, 2024 (TTM): -18.0

According to Cerevel Therapeutics's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -17.984. At the end of 2022 the company had a P/E ratio of -13.6.

P/E ratio history for Cerevel Therapeutics from 2020 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-13.6-30.81%
2021-19.642.9%
2020-13.7

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
7.65-142.56%๐Ÿ‡บ๐Ÿ‡ธ USA
26.8-249.23%๐Ÿ‡บ๐Ÿ‡ธ USA
8.56-147.62%๐Ÿ‡บ๐Ÿ‡ธ USA
16.2-190.07%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.